Post Type Archives: News

Pfizer announced the $4.9 billion acquisition of Metsera, a clinical-stage biopharmaceutical company specializing in treatments for obesity and cardiometabolic diseases, on September 22nd. The deal values Metsara at $47.50 per share, with additional payments of up to $22.50 per share contingent on completion of various clinical and regulatory milestones. The transaction is expected to close […]

FUJIFILM Biotechnologies, a world-leading contract development and manufacturing organization for biologics, vaccines, and advanced therapies, today announced a significant expansion of its global partnership with argenx SE, a global immunology company. As part of the expanded agreement, FUJIFILM Biotechnologies will initiate manufacturing of argenx’ drug substance for efgartigimod at the Holly Springs, North Carolina, site […]

Hundreds of entries received across 14 categories showcasing innovation, sustainability, and leadership in pharma Informa Markets, has today announced the shortlist for the CPHI Pharma Awards 2025, recognising outstanding achievements across pharmaceutical innovation, manufacturing, sustainability, leadership and women in pharma. The awards spotlight the companies and individuals pushing the boundaries of science and technology to […]

Kindeva, a global CDMO and drug delivery expert, has officially opened its new UK headquarters at Charnwood Campus Science Innovation and Technology Park, Loughborough. The facility represents a significant expansion in Kindeva’s MDI services and will develop and test next-generation propellants (NGP) as the industry prepares to move to more environmentally friendly products. Nestled in […]

2025 CPHI Pharma Award finalists Category  Accelerating Innovation This category celebrates advancements in technologies, products, processes, and services designed to mitigate the effects of global healthcare emergencies on individuals, patients, healthcare professionals, and communities. It recognises innovations such as drug and device development, rapid response initiatives, medical equipment, and the introduction of services, solutions, and […]

Avid Bioservices, Inc., a leading biologics contract development and manufacturing organization (CDMO), today announced the appointment of Kenneth Bilenberg as its new Chief Executive Officer (CEO). A seasoned industry executive with more than 20 years of experience, Bilenberg most recently served as Chief Operating Officer of Fujifilm Biotechnologies, leading global operations across modalities and scale, […]

FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the Life Science market, today announced the commercial launch of BalanCD HEK293 Perfusion A. Designed to expand and augment the company’s portfolio of gene therapy application solutions, BalanCD HEK293 Perfusion A uses suspension HEK293 cells and perfusion technology to provide […]

Chrysalis, a leading GMP cleanroom hosting and support services partner for advanced therapy and biopharma innovators, is pleased to announce the appointment of Adam Bartley as its Chief Operating Officer (COO). In this role, Bartley will lead day-to-day operations and growth across Chrysalis’ cleanroom infrastructure, environmental monitoring, and support service teams. He joins the executive […]

Novo Nordisk announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has approved an update to the Rybelsus® (oral semaglutide) label to reflect the cardiovascular benefits seen in the SOUL trial. SOUL was a phase 3b trial carried out to evaluate the effect of Rybelsus® on cardiovascular outcomes in people with […]

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, announced the expansion of its AbZelectPRO™ cell line development (CLD) platform with the launch of two next-generation Glutamine Synthetase (“GS”) knockout CHO-K1 expression systems, including a double knockout ADCC+ platform for afucosylated proteins. The addition of the new GS knockout cell lines will further […]